Related Experiment Video
Updated: Aug 14, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Charge-dependent targeting: results in six tumor cell lines
Marcela Márquez1, Sten Nilsson, Lena Lennartsson
1Karolinska Institute, Cancer Center Karolinska, S-17176 Stockholm, Sweden.
Cationic dextran (CatDex) effectively inhibited the growth of six tumor cell lines by interacting with sialic acid on cell surfaces. This suggests a potential new cancer treatment strategy, with clinical studies planned.
Area of Science:
- Biochemistry
- Materials Science
- Oncology
Background:
- Malignant cells exhibit enhanced surface sialylation, resulting in a negative charge.
- This negative charge presents a potential target for therapeutic interventions.
Purpose of the Study:
- To investigate the effect of a cationic polymer, cationic dextran (CatDex), on tumor cell growth.
- To explore the interaction between CatDex and tumor cell surface sialic acid.
Main Methods:
- Cationic dextran (CatDex) was synthesized and characterized.
- A fluorimetric cytotoxicity assay (FMCA) was employed to assess cell survival.
- Six human tumor cell lines were incubated with varying concentrations of CatDex, and interactions were visualized using fluorescence microscopy.
Main Results:
- CatDex demonstrated a concentration-dependent inhibition of tumor cell growth.
- A substitution of 20-22% in CatDex resulted in 20-95% growth inhibition, varying by tumor type.
- Higher substitution levels led to complete cell death across all tested tumor cell lines, with significant cell membrane interaction observed.
Conclusions:
- Cationic dextran induces cell death in multiple tumor cell lines, likely by binding to anionic sialic acid residues.
- This interaction appears to cause critical disturbances in the cell membrane, leading to cell death.
- The findings suggest CatDex as a promising candidate for novel cancer treatment strategies, warranting further clinical investigation.
More Related Videos
09:33Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
09:45Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology
Published on: November 14, 2025